Frontiers in Immunology (Apr 2025)
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment
- Victoria A. Jennings,
- Reah Rumbold-Hall,
- Gemma Migneco,
- Tyler Barr,
- Katrina Reilly,
- Nicola Ingram,
- Isabelle St Hilare,
- Samuel Heaton,
- Noura Alzamel,
- David Jackson,
- Christy Ralph,
- Susan Banerjee,
- Iain McNeish,
- John C. Bell,
- Alan A. Melcher,
- Carolina Ilkow,
- Graham P. Cook,
- Fiona Errington-Mais
Affiliations
- Victoria A. Jennings
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Reah Rumbold-Hall
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Gemma Migneco
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Tyler Barr
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Katrina Reilly
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Nicola Ingram
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Isabelle St Hilare
- Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada
- Samuel Heaton
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Noura Alzamel
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- David Jackson
- Leeds Cancer Centre, St James’s Hospital, Leeds, United Kingdom
- Christy Ralph
- Leeds Cancer Centre, St James’s Hospital, Leeds, United Kingdom
- Susan Banerjee
- The Royal Marsden Hospital, Fulham Road, London, United Kingdom
- Iain McNeish
- Department of Cancer and Surgery, Imperial College London, London, United Kingdom
- John C. Bell
- Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada
- Alan A. Melcher
- The Institute of Cancer Research, Divisions of Radiotherapy and Imaging and Breast Cancer Research, Chester Beatty Laboratories, London, United Kingdom
- Carolina Ilkow
- Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada
- Graham P. Cook
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- Fiona Errington-Mais
- Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom
- DOI
- https://doi.org/10.3389/fimmu.2025.1601201
- Journal volume & issue
-
Vol. 16
Abstract
No abstracts available.Keywords